557 related articles for article (PubMed ID: 16466513)
1. Necrolytic migratory erythema.
Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
[TBL] [Abstract][Full Text] [Related]
2. Rapid resolution of necrolytic migratory erythema after glucagonoma resection.
Smith AP; Doolas A; Staren ED
J Surg Oncol; 1996 Apr; 61(4):306-9. PubMed ID: 8628004
[TBL] [Abstract][Full Text] [Related]
3. [Glucagonoma revealed by necrolytic migratory erythema].
Bonaventure C; Merle P; Grezard P; Ruiz JM; Chevallier M; Scoazec JY; Trepo C
Gastroenterol Clin Biol; 2003 Feb; 27(2):230-2. PubMed ID: 12658134
[TBL] [Abstract][Full Text] [Related]
4. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma.
Technau K; Renkl A; Norgauer J; Ziemer M
Eur J Dermatol; 2005; 15(2):110-2. PubMed ID: 15757825
[TBL] [Abstract][Full Text] [Related]
5. Necrolytic migratory erythema: unresolved problems in diagnosis and pathogenesis. A case report and literature review.
Kasper CS
Cutis; 1992 Feb; 49(2):120-2, 125-8. PubMed ID: 1563284
[TBL] [Abstract][Full Text] [Related]
6. Glucagonoma syndrome: a case report.
Shyr YM; Su CH; Lee CH; Wu CW; Lui WY
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Sep; 62(9):639-43. PubMed ID: 10502856
[TBL] [Abstract][Full Text] [Related]
7. [Facial erythema and pancreatic glucagonoma].
Erce C; Morales DJ; Diego L; Mazorra F; García de Polavieja M
Rev Esp Enferm Dig; 1997 Feb; 89(2):137-8. PubMed ID: 9115822
[TBL] [Abstract][Full Text] [Related]
8. [The glucagonoma syndrome].
Rappersberger K; Wolff-Schreiner E; Konrad K; Wolff K
Hautarzt; 1987 Oct; 38(10):589-98. PubMed ID: 2824404
[TBL] [Abstract][Full Text] [Related]
9. Necrolytic migratory erythema associated with glucagonoma syndrome: a case report.
Dal Coleto CC; de Mello AP; Piquero-Casals J; Lima FR; Vilela MA; Festa-Neto C; Sanches JA
Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(6):183-8. PubMed ID: 11836542
[TBL] [Abstract][Full Text] [Related]
10. [Necrolytic migratory erythema: glucagonoma syndrome. Clinical and histological aspects].
Wilkinson DS
Ann Med Interne (Paris); 1984; 135(8):654-7. PubMed ID: 6099068
[TBL] [Abstract][Full Text] [Related]
11. [Recurrent glucagonoma 20 years after surgical resection].
Pautrat K; Bretagnol F; de Muret A; de Calan L
Gastroenterol Clin Biol; 2003 Dec; 27(12):1163-5. PubMed ID: 14770122
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience in diagnosis and treatment of glucagonoma syndrome.
Zhang M; Xu X; Shen Y; Hu ZH; Wu LM; Zheng SS
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):473-5. PubMed ID: 15313692
[TBL] [Abstract][Full Text] [Related]
13. [The question of surgical therapy for necrolytic migratory erythema, a cutaneous disease].
Siegel R; Linse R; Rau B
Chirurg; 2006 Jun; 77(6):535-8. PubMed ID: 16362349
[TBL] [Abstract][Full Text] [Related]
14. [Necrolytic migratory erythema as the first manifestation of glucagonoma].
Chang CH; Sheu HM; Cheng GS; Yu HS
J Formos Med Assoc; 1991 Dec; 90(12):1240-5. PubMed ID: 1686896
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural studies of necrolytic migratory erythema.
Ohyama K; Kitoh M; Arao T
Arch Dermatol; 1982 Sep; 118(9):679-82. PubMed ID: 6287944
[TBL] [Abstract][Full Text] [Related]
16. A patient with long-standing skin lesions. Necrolytic migratory erythema.
Netea RT; Erceg A; Pieters G; Hermus AR
Neth J Med; 2004 Dec; 62(11):453, 462. PubMed ID: 15685896
[No Abstract] [Full Text] [Related]
17. What is your diagnosis? Necrolytic migratory erythema associated with a glucagonoma.
Chaw L; Krop TM; Hood AF
Cutis; 2008 Jan; 81(1):25, 30-2. PubMed ID: 18306843
[No Abstract] [Full Text] [Related]
18. Necrolytic migratory erythema and pancreatic glucagonoma.
Rodríguez G; Vargas E; Abaúnza C; Cáceres S
Biomedica; 2016 Jun; 36(2):176-81. PubMed ID: 27622478
[TBL] [Abstract][Full Text] [Related]
19. Necrolytic migratory erythema as the only presenting sign of a glucagonoma.
Johnson SM; Smoller BR; Lamps LW; Horn TD
J Am Acad Dermatol; 2003 Aug; 49(2):325-8. PubMed ID: 12894090
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of canine necrolytic migratory erythema (superficial necrolytic dermatitis) due to metastatic glucagonoma with octreotide.
Oberkirchner U; Linder KE; Zadrozny L; Olivry T
Vet Dermatol; 2010 Oct; 21(5):510-6. PubMed ID: 20500495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
